Brind.

TSHA is seeking FDA approval for TSHA-102, with clinical data being tracked in the ASPIRE trial.

1 report, 1 independent Updated Jun 11

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

TSHA FDA

Keep exploring

The entities involved

TSHA
musical artist

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jun 11yahoo.com